The year was 1998, location, Italian Alps. Jim and I were attending an intimate Pezcoller meeting organized by David Livingston. At that meeting, Jim presented something I had never seen in the entirety of my career—the eradication of cancer in mice following treatment with an antibody designed to inhibit a T cell checkpoint mechanism.
European Commission has approved Braftovi in combination with Mektovi for the treatment of adult patients with unresectable or metastatic melanoma with a BRAFV600 mutation, as detected by a validated test. This approval is applicable to all 28 European Union member states, as well as Liechtenstein, Iceland and Norway.
OBI Pharma, Inc., a Taiwan biopharma company, announced that FDA has granted Orphan Drug Designation for OBI-3424 for the treatment of acute lymphoblastic leukemia.
IMV Inc. announced that investigators are evaluating IMV's lead candidate, DPX-Survivac, in combination with low dose cyclophosphamide and Merck's checkpoint inhibitor Keytruda (pembrolizumab), in patients with persistent or recurrent/refractory diffuse large B-cell lymphoma.
Jean-Charles SoriaTony MokPasi JänneMargaret FotiThe European Society for Medical Oncology has announces four distinguished oncology professionals who will receive its annual awards during the ESMO 2018 Congress in Munich. The awardees are:
M. Michele Blackwood was named chief of breast surgery at Rutgers Cancer Institute of New Jersey.
Subha Madhavan was named chief data scientist and director of its new Office for Health Data Science and Informatics at Georgetown University Medical Center.
AbbVie announced a donation of $5 million to Family Reach to support the organization's efforts to alleviate the financial burden of cancer on pediatric patients and families across the United States.
Six new health systems have committed to sharing data upon joining the Syapse Learning Health Network:  Ascension, Banner Health, Inova Health, LSU Health, OhioHealth, and Seoul National University Hospital.
As residents across the southeastern United States face the early impact of Hurricane Florence, CancerCare prepares to offer emotional and financial support to cancer patients impacted by the storm.
